Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Minority Interest (2016 - 2025)

Historic Minority Interest for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $12.9 million.

  • HUTCHMED (China)'s Minority Interest rose 775.1% to $12.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $12.9 million, marking a year-over-year increase of 775.1%. This contributed to the annual value of $1.5 billion for FY2024, which is 704.65% down from last year.
  • HUTCHMED (China)'s Minority Interest amounted to $12.9 million in Q2 2025, which was up 775.1% from $1.5 billion recorded in Q4 2024.
  • Over the past 5 years, HUTCHMED (China)'s Minority Interest peaked at $1.6 billion during Q4 2023, and registered a low of $3.4 million during Q4 2022.
  • Its 5-year average for Minority Interest is $371.2 million, with a median of $28.9 million in 2021.
  • Over the last 5 years, HUTCHMED (China)'s Minority Interest had its largest YoY gain of 4842395.55% in 2023, and its largest YoY loss of 6550.72% in 2023.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Minority Interest stood at $28.9 million in 2021, then plummeted by 88.28% to $3.4 million in 2022, then soared by 48423.96% to $1.6 billion in 2023, then fell by 6.71% to $1.5 billion in 2024, then crashed by 99.16% to $12.9 million in 2025.
  • Its Minority Interest stands at $12.9 million for Q2 2025, versus $1.5 billion for Q4 2024 and $11.9 million for Q2 2024.